| |
| |
|
| Insider
Information: |
Crowley John F |
| Relationship: |
Director |
| City: |
Cranbury |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
590,194 |
|
|
Indirect Shares
|
97,759 |
|
|
| Direct
Value |
$6,353,484 |
|
|
|
Indirect Value
|
$688,536 |
|
|
| Total
Shares |
687,953 |
|
|
| Total
Value |
$7,042,020 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Amicus Therapeutics Inc |
FOLD |
|
2024-03-01 |
573,478 |
2024-03-01 |
64,895 |
Premium* |
|
|
Intellia Therapeutics, Inc. |
NTLA |
Director |
2023-06-14 |
11,716 |
2021-06-23 |
0 |
Premium* |
|
|
Entrada Therapeutics, Inc. |
TRDA |
Director |
2022-01-12 |
5,000 |
2022-01-12 |
32,864 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
298 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 7 of 12
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| FOLD |
Amicus Therapeutics Inc |
Executive Chairman |
• • – |
2022-08-15 |
4 |
AS |
$12.28 |
$128,585 |
D/D |
(10,468) |
878,711 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Executive Chairman |
• • – |
2022-09-01 |
4 |
AS |
$11.30 |
$128,162 |
D/D |
(11,346) |
867,365 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Executive Chairman |
• • – |
2022-10-03 |
4 |
AS |
$10.75 |
$121,926 |
D/D |
(11,346) |
845,551 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Executive Chairman |
• • – |
2022-10-17 |
4 |
AS |
$10.90 |
$114,148 |
D/D |
(10,468) |
835,083 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Executive Chairman |
• • – |
2022-11-01 |
4 |
AS |
$10.32 |
$117,052 |
D/D |
(11,346) |
823,737 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Executive Chairman |
• • – |
2022-11-15 |
4 |
AS |
$11.64 |
$121,866 |
D/D |
(10,468) |
813,269 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Executive Chairman |
• • – |
2022-12-01 |
4 |
AS |
$12.20 |
$138,473 |
D/D |
(11,347) |
801,922 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Executive Chairman |
• • – |
2022-12-15 |
4 |
AS |
$12.15 |
$127,172 |
D/D |
(10,468) |
791,454 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Executive Chairman |
• • – |
2023-01-09 |
4 |
AS |
$11.43 |
$972,954 |
D/D |
(85,102) |
885,229 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Executive Chairman |
• • – |
2023-02-01 |
4 |
AS |
$13.11 |
$1,931,342 |
D/D |
(147,316) |
1,004,669 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Executive Chairman |
• • – |
2023-02-15 |
4 |
AS |
$12.94 |
$78,217 |
D/D |
(6,044) |
998,625 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Executive Chairman |
• • – |
2023-03-01 |
4 |
AS |
$13.29 |
$81,093 |
D/D |
(6,044) |
992,581 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Executive Chairman |
• • – |
2023-03-15 |
4 |
AS |
$11.34 |
$68,547 |
D/D |
(6,044) |
986,537 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chairman, President & CEO |
• • – |
2010-03-02 |
4 |
B |
$3.69 |
$43,904 |
D/D |
11,898 |
71,634 |
2.81 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Executive Chairman |
• • – |
2011-06-17 |
4 |
B |
$6.04 |
$120,800 |
D/D |
20,000 |
99,867 |
2.81 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2011-08-11 |
4 |
B |
$4.20 |
$42,000 |
D/D |
10,000 |
109,867 |
2.81 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2017-09-26 |
4 |
B |
$14.36 |
$20,032 |
D/D |
1,395 |
328,001 |
2.81 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
Director |
– • – |
2022-01-12 |
4 |
B |
$9.72 |
$48,575 |
D/D |
5,000 |
5,000 |
2.39 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2017-06-15 |
4 |
D |
$8.79 |
$43,994 |
D/D |
(5,005) |
326,606 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2019-06-17 |
4 |
D |
$11.35 |
$2,327 |
D/D |
(205) |
750,194 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2019-12-31 |
4 |
D |
$9.74 |
$322,228 |
D/D |
(33,083) |
702,611 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2020-01-03 |
4 |
D |
$9.18 |
$183,545 |
D/D |
(19,994) |
939,290 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2020-01-10 |
4 |
D |
$9.46 |
$607,937 |
D/D |
(64,264) |
1,038,339 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2020-01-31 |
4 |
D |
$8.84 |
$176,747 |
D/D |
(19,994) |
938,345 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2020-06-15 |
4 |
D |
$11.14 |
$1,816 |
D/D |
(163) |
900,023 |
0 |
- |
|
298 Records found
|
|
Page 7 of 12 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
